Home PRODUCT NEWS ABOUT PARTNERSHIP
EN
CN
Good News | Super Bo Medical has won the first place in the Diagnosis and Treatment Equipment category of the 7th China Medical Device Innovation and Entrepreneurship Competition
Release time:2025-11-12 17:15:07 Number of views:28

On September 27, 2024, the 7th China Medical Device Innovation and Entrepreneurship Competition Diagnosis and Treatment Equipment Category Competition was held in Gaochun, Nanjing, Jiangsu Province. Chaobo Medical's independent innovation project: Knife Art, Electric Heating Escort: Low loss and Efficient Cutting Hemostasis System is committed to independent innovation of electrosurgical products, breaking the conventional pattern of electrosurgical treatment and winning the first prize in the diagnostic and treatment equipment category competition.

 

 

This competition is jointly organized by the National Medical Device Industry Technology Innovation Alliance and the Medical Device Innovation Network, and has received strong support from the Evaluation Center of Jiangsu Provincial Drug Administration, Jiangsu Medical Device Inspection Institute, Jiangsu Gaochun Economic Development Zone Management Committee, and the Medical Device Research and Development Agency Service Platform. This competition has invited many academicians and industry experts to serve as the chairman of the judging panel, and has formed a strong judging team with more than 150 experts, ensuring the professionalism and authority of the competition. Professional evaluations were conducted on the project by assessing its innovation, clinical value, social value, and other dimensions.

 

Project Introduction: Innovative Technology Leads the Future

There are various types of energy surgical instruments with excellent performance and promising market prospects. By calculating the total market size of the three major sub segments of high-frequency electric knives, ultrasonic knives, and plasma knives in China's energy surgical instruments, it has grown from 19.006 billion yuan in 2018 to 30.76 billion yuan in 2021, with a compound growth rate of 17.41%. It is expected that the total market size will reach 67.217 billion yuan by 2025. These three major segmented markets account for over 80% of the energy surgical instrument market. The ultrasonic knife market is the largest segmented market for domestic substitution space. The market size exceeded 12.5 billion yuan in 2021, with a compound annual growth rate of 18.65% from 2018 to 2021. It is expected that the domestic ultrasonic knife market will reach 30.55 billion yuan by 2025, with a compound annual growth rate of 24.88% from 2021 to 2025. At present, clinical surgical instruments are mainly monopolized by imported products, which are expensive. The market urgently needs new domestic substitute products with high performance and cost-effectiveness.

 

 

The award-winning low loss and efficient cutting and hemostasis system (Super Bo Knife) project by Super Bo Company is a groundbreaking minimally invasive surgical technology that combines new materials, new energy, and AI algorithms to achieve the same cutting and hemostasis effect as ultrasonic knives using non ultrasonic methods. During the cutting process, the tissue itself does not generate heat and there is no current passing through, so the tissue thermal damage is minimal and there is no tissue splashing effect. There is no need to worry about the side effects of tumor cell splashing and diffusion caused by the ultrasonic knife, and it is known as the next generation surgical knife in the field of surgery.

The Super Bo Knife includes an intelligent cutting hemostatic device and an intelligent cutting hemostatic blade head. This product has no current flowing through the human body, making it safer and even suitable for brain tissue, nerve tissue, and cardiac surgery; The cutting and coagulation effects are comparable to ultrasonic knives, but the cost is only one tenth of that of ultrasonic knives, which will undoubtedly overturn the market pattern of minimally invasive surgery. The low loss and efficient cutting and hemostasis system promotes the innovation of minimally invasive surgical medical devices in China, bringing new ways of minimally invasive surgical treatment for patients' diseases.

 

Competition Honor: Industry Recognition Helps Medical Innovation

The selection of the 7th (2024) China Medical Device Innovation and Entrepreneurship Competition is strict and highly professional. The participating projects not only need to demonstrate the innovation of technology, but also need to prove their practical application and transformation prospects in the medical industry through practical application. The Chaobo Knife project of Chaobo Medical stood out from numerous participating projects due to its outstanding performance in product technological innovation, market potential, and future development prospects. It received high praise from the judging experts and ultimately won the first prize in the diagnosis and treatment equipment category competition. This honor is not only a high recognition of the company's technological innovation capability, but also reflects its outstanding contribution to promoting the industrialization of medical devices.

 

 

Future Prospects

Based in China and looking to the world, Chaobo Medical actively responds to the call for domestic substitution of high-end medical devices, always focusing on the field of "electrosurgery", and is committed to researching and promoting more innovative products and technologies. This award is a full recognition of the hard work and technological innovation of the Chaobo Medical team, and it is also the driving force for Chaobo Medical to continue to deepen its cultivation in the medical and health field and promote technological breakthroughs. In the future, Chaobo Medical will continue to strive to create more products and solutions that meet the needs of patients and promote innovation in the medical industry